The Tate Cancer Center at University of Maryland Baltimore Washington Medical Center opened in 2003 and is named for community philanthropists Creston and Betty Jane Tate. The center was a $17.4 million project that was completed to provide cancer patients with high-quality outpatient care conveniently located on the hospital's campus, all under one roof.


  • Accredited by the Commission on Cancer as an Academic Comprehensive Cancer Program (ACAD). ACADs are cancer centers that provide post graduate medical education, assesses more than 500 newly diagnosed cancer patients each year, offer a full range of diagnostic and treatment services, and participate in cancer related clinical research. Only 13 percent of all cancer programs in the nation have achieved this status.
  • Accredited by the American College of Surgeons Commission on Cancer, which aims to improve cancer patient care through nationally recognized programs.
  • A member of The Alliance for Clinical Trials in Oncology, a national clinical trials network sponsored by the National Cancer Institute. The Alliance comprises nearly 10,000 cancer specialists at hospitals, medical centers and community clinics across the United States and Canada who offer their patients clinical trials for different types of cancer.

University of Maryland Cancer Network

The Tate Cancer Center is affiliated with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), and is part of the University of Maryland Cancer Network. The Network provides access to national experts, the latest treatments, leading edge technology, and promising clinical trials — all close to home. Learn more about the UM Cancer Network.

Annual Report

View the Tate Cancer Center's 2019 Annual Report.